BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27617129)

  • 1. Ultra-Rare Syndromes: The Example of Rubinstein-Taybi Syndrome.
    Spena S; Gervasini C; Milani D
    J Pediatr Genet; 2015 Sep; 4(3):177-86. PubMed ID: 27617129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum.
    López M; García-Oguiza A; Armstrong J; García-Cobaleda I; García-Miñaur S; Santos-Simarro F; Seidel V; Domínguez-Garrido E
    BMC Med Genet; 2018 Mar; 19(1):36. PubMed ID: 29506490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Whole Gene Deletion to Point Mutations of EP300-Positive Rubinstein-Taybi Patients: New Insights into the Mutational Spectrum and Peculiar Clinical Hallmarks.
    Negri G; Magini P; Milani D; Colapietro P; Rusconi D; Scarano E; Bonati MT; Priolo M; Crippa M; Mazzanti L; Wischmeijer A; Tamburrino F; Pippucci T; Finelli P; Larizza L; Gervasini C
    Hum Mutat; 2016 Feb; 37(2):175-83. PubMed ID: 26486927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: a Chinese girl like atypical Rubinstein-Taybi syndrome caused by a novel heterozygous mutation of the EP300 gene.
    Bai Z; Li G; Kong X
    BMC Med Genomics; 2023 Feb; 16(1):24. PubMed ID: 36797748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.
    Fergelot P; Van Belzen M; Van Gils J; Afenjar A; Armour CM; Arveiler B; Beets L; Burglen L; Busa T; Collet M; Deforges J; de Vries BB; Dominguez Garrido E; Dorison N; Dupont J; Francannet C; Garciá-Minaúr S; Gabau Vila E; Gebre-Medhin S; Gener Querol B; Geneviève D; Gérard M; Gervasini CG; Goldenberg A; Josifova D; Lachlan K; Maas S; Maranda B; Moilanen JS; Nordgren A; Parent P; Rankin J; Reardon W; Rio M; Roume J; Shaw A; Smigiel R; Sojo A; Solomon B; Stembalska A; Stumpel C; Suarez F; Terhal P; Thomas S; Touraine R; Verloes A; Vincent-Delorme C; Wincent J; Peters DJ; Bartsch O; Larizza L; Lacombe D; Hennekam RC
    Am J Med Genet A; 2016 Dec; 170(12):3069-3082. PubMed ID: 27648933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the EP300 gene.
    Negri G; Milani D; Colapietro P; Forzano F; Della Monica M; Rusconi D; Consonni L; Caffi LG; Finelli P; Scarano G; Magnani C; Selicorni A; Spena S; Larizza L; Gervasini C
    Clin Genet; 2015 Feb; 87(2):148-54. PubMed ID: 24476420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype analysis of ocular findings in Rubinstein-Taybi syndrome - A case report and review of literature.
    Jin E; Le H; Jewell A; Couser NL
    Ophthalmic Genet; 2024 Feb; 45(1):51-58. PubMed ID: 37017262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubinstein-Taybi Syndrome and Epigenetic Alterations.
    Korzus E
    Adv Exp Med Biol; 2017; 978():39-62. PubMed ID: 28523540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic heterogeneity in Rubinstein-Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300.
    Bartholdi D; Roelfsema JH; Papadia F; Breuning MH; Niedrist D; Hennekam RC; Schinzel A; Peters DJ
    J Med Genet; 2007 May; 44(5):327-33. PubMed ID: 17220215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubinstein-Taybi Syndrome: A Model of Epigenetic Disorder.
    Van Gils J; Magdinier F; Fergelot P; Lacombe D
    Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34202860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management.
    Milani D; Manzoni FM; Pezzani L; Ajmone P; Gervasini C; Menni F; Esposito S
    Ital J Pediatr; 2015 Jan; 41():4. PubMed ID: 25599811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First case report of inherited Rubinstein-Taybi syndrome associated with a novel EP300 variant.
    López M; Seidel V; Santibáñez P; Cervera-Acedo C; Castro-de Castro P; Domínguez-Garrido E
    BMC Med Genet; 2016 Dec; 17(1):97. PubMed ID: 27964710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS.
    Bartsch O; Schmidt S; Richter M; Morlot S; Seemanová E; Wiebe G; Rasi S
    Hum Genet; 2005 Sep; 117(5):485-93. PubMed ID: 16021471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome Sequencing Identification of EP300 Mutation in a Proband with Coloboma and Imperforate Anus: Possible Expansion of the Phenotypic Spectrum of Rubinstein-Taybi Syndrome.
    Masuda K; Akiyama K; Arakawa M; Nishi E; Kitazawa N; Higuchi T; Katou Y; Shirahige K; Izumi K
    Mol Syndromol; 2015 Jul; 6(2):99-103. PubMed ID: 26279656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubinstein-Taybi syndrome: New neuroradiological and neuropsychiatric insights from a multidisciplinary approach.
    Ajmone PF; Avignone S; Gervasini C; Giacobbe A; Monti F; Costantino A; Esposito S; Marchisio P; Triulzi F; Milani D
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jun; 177(4):406-415. PubMed ID: 29637745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome.
    Zimmermann N; Acosta AM; Kohlhase J; Bartsch O
    Eur J Hum Genet; 2007 Aug; 15(8):837-42. PubMed ID: 17299436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign and malignant tumors in Rubinstein-Taybi syndrome.
    Boot MV; van Belzen MJ; Overbeek LI; Hijmering N; Mendeville M; Waisfisz Q; Wesseling P; Hennekam RC; de Jong D
    Am J Med Genet A; 2018 Mar; 176(3):597-608. PubMed ID: 29359884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EP300-related Rubinstein-Taybi syndrome: Highlighted rare phenotypic findings and a genotype-phenotype meta-analysis of 74 patients.
    Cohen JL; Schrier Vergano SA; Mazzola S; Strong A; Keena B; McDougall C; Ritter A; Li D; Bedoukian EC; Burke LW; Hoffman A; Zurcher V; Krantz ID; Izumi K; Bhoj E; Zackai EH; Deardorff MA
    Am J Med Genet A; 2020 Dec; 182(12):2926-2938. PubMed ID: 33043588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubinstein-Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum.
    Hamilton MJ; Newbury-Ecob R; Holder-Espinasse M; Yau S; Lillis S; Hurst JA; Clement E; Reardon W; Joss S; Hobson E; Blyth M; Al-Shehhi M; Lynch SA; Suri M;
    Clin Dysmorphol; 2016 Oct; 25(4):135-45. PubMed ID: 27465822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report.
    Al-Qattan MM; Jarman A; Rafique A; Al-Hassnan ZN; Al-Qattan HM
    BMC Med Genet; 2019 Jan; 20(1):12. PubMed ID: 30635043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.